Indications and contraindications for contrast-enhanced MRI and CT during pregnancy;Indikationen und kontraindikationen kontrastmittelverstärkter MRT- und CT-untersuchungen in der schwangerschaft

Radiologe

Volumn 47, Issue 9, 2007, Pages 774-777

  Junkermann, H ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Contrast media; Fetus; Gadolinium; Pregnancy; Toxicity

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; IODINE; THYROTROPIN;

BREAST FEEDING EDUCATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HUMAN; HYPOTHYROIDISM; INTESTINE; MOTHER; NEWBORN SCREENING; NUCLEAR MAGNETIC RESONANCE IMAGING; NURSING; PEDIATRICS; PREGNANCY; PREGNANT WOMAN; REVIEW;

BREAST FEEDING; CONTRAST MEDIA; FEMALE; FETUS; HUMANS; HYPOTHYROIDISM; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; NEONATAL SCREENING; PREGNANCY; THYROTROPIN; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34648840473     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-007-1542-4     Document Type: Review

References (19)

1. Bona G, Zaffaroni M, Defilippi C et al. (1992) Effects of iopamidol on neonatal thyroid function. Eur J Radiol 14: 22-25
2. De Santis M, Straface G, Cavaliere AF et al. (2007) Gadolinium periconceptional exposure: pregnancy and neonatal outcome. Acta Obstet Gynecol Scand 86: 99-101
3. Donandieu AM, Idee JM, Doucet D et al. (1996) Toxicologic profile of iobitridol, a new nonionic low-osmolality contrast medium. Acta Radiol 400 [suppl]: 17-24
4. Giraud JR, Dugue-Marechaud M, Fizazi T et al. (1983) [Intravenous urography in pregnancy and the risks of fetal hypothyroidism]. J Gynecol Obstet Biol Reprod (Paris) 12: 45-49
5. Hylton NM (2000) Suspension of breast-feeding following gadopentetate dimeglumine administration. Radiology 216: 325-326
6. Kawaguchi T, Sagami F, Tirone P et al. (1999) [Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155) (2)-Combined study of effects on fertility and embryo-fetal toxicity in female rats by intravenous administration]. J Toxicol Sci 24 [suppl 1]: 71-78
7. Kubik-Huch RA, Gottstein-Aalame NM, Frenzel T et al. (2000) Gadopentetate dimeglumine excretion into human breast milk during lactation. Radiology 216: 555-558
8. Miething R (1981) Transitorische Hypothyreose bei Früh- und Neugeborenen nach Amniofetografie während der Schwangerschaft. Klin Pädiatr 193: 372-374
9. Morisetti A, Bussi S, Tirone P, de Haen C (1999) Toxicological safety evaluation of gadobenate dimeglumine 0.5 M solution for injection (MultiHance), a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 23 [suppl 1]: S207-S217
10. Morisetti A, Tirone P, Luzzani F, de Haen C (1994) Toxicological safety assessment of iomeprol, a new X-ray contrast agent. Eur J Radiol 18 [suppl 1]: S21-S31
11. Norman A, Cochran ST, Sayre JW (2001) Meta-analysis of increases in micronuclei in peripheral blood lymphocytes after angiography or excretory urography. Radiat Res 155: 740-743
12. Okuda Y, Sagami F, Tirone P et al. (1999) [Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155) (3)-study of embryo-fetal toxicity in rabbits by intravenous administration]. J Toxicol Sci 24 [suppl 1]: 79-87
13. Rofsky NM, Pizzarello DJ, Weinreb JC et al. (1994) Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine. J Magn Reson Imaging 4: 805-807
14. Steger-Hartmann T, Graham PB, Muller S, Schweinfurth H (2006) Preclinical safety assessment of vasovist (gadofosveset trisodium), a new magnetic resonance imaging contrast agent for angiography. Invest Radiol 41: 449-459
15. Storm W (1986) Transitorische Hypothyreose des Neugeborenen nach Amnionfetographie mit jodhaltigem Kontrastmittel. Geburtsh Frauenheilkd 46: 185-186
16. Stubbe P, Heidemann P, Schurnbrand P, Ulbrich R (1980) Transient congenital hypothyroidism after amniofetography. Eur J Pediatr 135: 97-99
17. Tauber U, Weinmann HJ, Panzer M et al. (1986) Whole-body autoradiographic studies in rats with gadolinium-diethylenetriaminepentaacetic acid, a new contrast agent for magnetic resonance imaging. Arzneimittelforschung 36: 1089-1091
18. Webb JA, Thomsen HS, Morcos SK (2005) The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 15: 1234-1240
19. Weber G, Vigone MC, Rapa A et al. (1998) Neonatal transient hypothyroidism: aetiological study. Italian Collaborative Study on Transient Hypothyroidism. Arch Dis Child Fetal Neonatal Ed 79: F70-F72